Basic information Safety Supplier Related

MOFEBUTAZONE

Basic information Safety Supplier Related

MOFEBUTAZONE Basic information

Product Name:
MOFEBUTAZONE
Synonyms:
  • 2fdbp
  • 2-phenyl-3,5-dihydroxy-4-butylpyrazolidine
  • 4-butyl-1-phenyl-3,5-dioxopyrazolidine
  • 4-butyl-1-phenyl-3,5-pyrazolidinedione
  • 4-butyl-1-phenyl-5-pyrazolidinedione
  • arcomonoltablets
  • mobutazon
  • mobuzon
CAS:
2210-63-1
MF:
C13H16N2O2
MW:
232.28
EINECS:
218-641-1
Mol File:
2210-63-1.mol
More
Less

MOFEBUTAZONE Chemical Properties

Melting point:
102-103°
Boiling point:
374.44°C (rough estimate)
Density 
1.1099 (rough estimate)
refractive index 
1.6450 (estimate)
storage temp. 
Room Temperature
solubility 
DMSO (Slightly), Methanol (Sparingly)
form 
Solid
pka
5.22±0.10(Predicted)
color 
White to Off-White
More
Less

Safety Information

Toxicity
LD50 i.v. in mice: 600 mg/kg (Schoetensack)
More
Less

MOFEBUTAZONE Usage And Synthesis

Originator

Butaphen,Wiedenmann

Uses

Mofebutazone is an anti-inflammatory drug used on the gastrointestinal and renal tissues.

Definition

ChEBI: A pyrazolidine that is phenylbutazone lacking one of the phenyl substituents. It is used for treatment of joint and muscular pain.

Manufacturing Process

A mixture comprising 108 g of phenyl hydrazine and 216 g of the diethyl ester of n-butylmalonic acid is heated on an oil bath at 170°-180°C for 12 hours. The residue is taken up with water in which an alkaline compound has been dissolved and acetic acid is added to precipitate 4-n-butyl-2-phenylpyrazolidine-3,5-dione. The product is a white crystalline solid having a MP: 103°C. It is soluble in acetone and benzene, soluble in hot condition in methanol and ethanol and insoluble in water.

brand name

Arcobutine;Buta lyseen;Chemiartrol;Clinit;Diadin;Fenartril;Jovapyrin;Mobutazone;Mofasal;Mofesal;Monazone;Monbutina;Monobutina;Monofen;Monomil;Monoprine;Monozon;Mozol;Rheuma-cur;Rheumaorctat;Rivodol;Sodepyrine b 1.

Therapeutic Function

Antirheumatic, Analgesic, Antiinflammatory

World Health Organization (WHO)

Mofebutazone, a pyrazolone with anti-inflammatory, analgesic and antipyretic activity, was introduced in 1962 for the treatment of rheumatic disorders. As it is structurally related to phenylbutazone it is subjected to rigorously restricted indications by some national regulatory authorities. See WHO comment for phenylbutazone.

Clinical Use

Mofebutazone is a nonsteroidal anti-inflammatory drug used as sodium salt for the treatment of mild to moderate pain including inflammatory and degenerative rheumatic disorders and musculoskeletal pain. Mofebutazone can be given by oral, rectal (900–1200 mg/d), or intramuscular administration (650 mg/d).

MOFEBUTAZONESupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-400-6206333 18521732826
Email
market@aladdin-e.com
Shanghai QianYan Bio-technology Co., Ltd
Tel
02781293128
Email
orders@biochemsafebuy.com
Shandong Xiya Chemical Co., Ltd.
Tel
4009903999 13395398332
Email
sales@xiyashiji.com